Merck & Co. Total Liabilities & Equity decreased by 6.0% to $128.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $115.12B to $128.69B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 8.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in this figure generally indicates an expansion of the company's asset base and operational scale.
This metric represents the sum of all liabilities and total stockholders' equity, which must equal the total assets of t...
Used to compare the overall size and scale of operations across peer companies.
total_liabilities_and_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $90.69B | $93.49B | $105.69B | $106.67B | $107.10B | $107.08B | $109.16B | $107.80B | $104.47B | $106.73B | $106.68B | $105.85B | $112.63B | $117.53B | $117.11B | $115.12B | $117.52B | $129.55B | $136.87B | $128.69B |
| QoQ Change | — | +3.1% | +13.0% | +0.9% | +0.4% | -0.0% | +1.9% | -1.2% | -3.1% | +2.2% | -0.0% | -0.8% | +6.4% | +4.4% | -0.4% | -1.7% | +2.1% | +10.2% | +5.7% | -6.0% |
| YoY Change | — | — | — | — | +18.1% | +14.5% | +3.3% | +1.1% | -2.5% | -0.3% | -2.3% | -1.8% | +7.8% | +10.1% | +9.8% | +8.8% | +4.3% | +10.2% | +16.9% | +11.8% |